AlternativeMed
Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

Plus 6,743 TCM formulas connecting herbs together
🏥 Disease / Health Topic

Squamous Non-Small Cell Lung Cancer

11
Clinical Trials
0
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT00974584
A Study of the Safety and Pharmacology Of PI3-Kinase Inhibitor GDC-0941 In Combination With Either Paclitaxel And Carboplatin (With or Without Bevacizumab) or Pemetrexed, Cisplatin, And Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer
Completed · Phase 1
NCT01160601
Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer
Completed · Phase 2
NCT01366131
Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease (NILE)
Completed · Phase 2
📊 Sample Meta-Analyses
None linked yet.
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Squamous Non-Small Cell Lung Cancer
🏥 Names
Disease Name
Squamous Non-Small Cell Lung Cancer
Topic Type
disease
🧬 Ontology Classifications
DisGeNET Type
disease
UMLS Type
Neoplastic Process
MeSH Class
Respiratory Tract Diseases; Neoplasms
🔗 External References
DisGeNET
C4509816
🔍 Raw view — every non-empty column on this row (21 fields)
name
Squamous Non-Small Cell Lung Cancer
topic type
disease
disgenet disease type
disease
umls disease type
Neoplastic Process
mesh disease class
Respiratory Tract Diseases; Neoplasms
umls disease type id
T191
mesh disease class id
C04; C08
herb disease id
HBDIS026750
disgenet id
C4509816

⚗️ Related Ingredients

1 · shared evidence

📋 Clinical Trials

11 · subject of clinical study
NCT00974584 A Study of the Safety and Pharmacology Of PI3-Kinase Inhibitor GDC-0941 In Combi
→ Non-Squamous Non-Small Cell Lung Cancer
NCT01160601 Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untrea
→ Non-Squamous Non-Small Cell Lung Cancer
NCT01366131 Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carbop
→ Non-Squamous Non-Small Cell Lung Cancer
NCT01496742 A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab (Avastin) Plus P
→ Non-Squamous Non-Small Cell Lung Cancer
NCT01519804 A Study of Onartuzumab (MetMAb) Versus Placebo in Combination With Paclitaxel Pl
→ Non-Squamous Non-Small Cell Lung Cancer
NCT02106546 Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Ca
→ Squamous Non-Small Cell Lung Cancer
NCT02264990 Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's
→ Non-squamous Non-small Cell Lung Cancer
NCT02367794 A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carbopla
→ Squamous Non-Small Cell Lung Cancer
NCT03169335 Efficacy and Safety of QL1101 and Avastin® Respectively Combined With Paclitaxel
→ Non-squamous Non-small Cell Lung Cancer
NCT01763671 Paclitaxel-bevacizumab in Advanced Lung Cancer
→ Non-squamous Non-small Cell Lung Cancer
NCT03366480 A Study to Assess the Efficacy and Safety of ABTL0812
→ Endometrial Cancer|Squamous Non-Small Cell Lung Ca
How relationships are computed
  • Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
  • Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
  • Herb ↔ Ingredient: empty — needs HERB_herb_ingredient import
  • Ingredient ↔ Target: empty — needs HERB_ingredient_target import
  • Target ↔ Disease: empty — needs HERB_target_disease import
  • Herb → Target → Disease (full chemical spine): awaiting Phase 2e link tables